scorecardresearch
Add as a preferred source on Google
Thursday, January 15, 2026
TopicIndian pharmaceutical

Topic: Indian pharmaceutical

Chhindwara’s Coldrif deaths show India’s dangerous irony—pharmacy of the world, failing at home

India’s pharmaceutical sector is valued at $50 billion. It has built its reputation on affordability and accessibility. The deaths in Chhindwara tell a different story.

Trump’s 100% pharma tariffs call for Indian firms to reimagine drug exports. Act quickly

If the US is attempting to force localisation, India should respond aggressively with a proactive agenda. Here’s how.

On Camera

From Bronze Age migrations to British Raj—how ideas stopped flowing between India and Iran

As early states developed in the Iranian plateau and northern India, ideas continued to circulate between the steppe and the settlements of the Iranian plateau and the Punjab plains.

Geoeconomic confrontation top trigger for global crisis, cyber insecurity biggest risk for India—WEF

WEF report flags growing erosion of multilateralism, long considered stabilising force. 'Declining trust, heightened protectionism are threatening trade, investment.'

The curious case of Pakistan’s JF-17 orders

Pakistan lacks capacity to deliver aircraft at pace suggested by its claimed contracts as it depends on China for avionics, electronic warfare, weapons, and on Russia for engines. 

Thank you Donald Trump, again. India now has reason to shed fear of trade deals and risky reform

UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.